IsoRay announces Cesium-131 brachytherapy and external beam radiation dual therapy prostate cancer study

Links shared publicly online about this topic.

205
total visits

IsoRay announces Cesium-131 brachytherapy and external beam radiation dual therapy prostate cancer study

IsoRay Inc., announced today a new dual therapy study using Cesium-131 brachytherapy (internal radiation therapy) and external beam radiation. Multiple sites have now received Institutional Review Board (IRB) approval for this study which will examine the efficacy of combining intensity modulated radiation (IMRT) with Cesium-131 brachytherapy to treat intermediate and high risk early stage prostate cancer.

View full resource at news-medical.net

Tags: Cancer, Prostate Cancer, Prostate, Men's Health, Oncology, News, Radiation